Responsible for leading Tonix’s clinical development for vaccines and antivirals including our next generation vaccine for smallpox and monkeypox (mpox), TNX-801, our NIH/NIAID Project NextGen selected vaccine for COVID-19, TNX-1800. Lead Medical Affairs for marketed CNS migraine drugs Tosymra and Zembrace. Provide leadership in FDA submissions, clinical trial design and CRO management.

Develop clinical trial proposals and provide strategic programatic advice to Biotech companies. Work with Business Development and Operations to identify new opportunities and assure clinical trial execution success.

Medical Affairs and Clinical Development responsibility to grow PPD's AES vaccine business segment and to craft clinical trial solutions (Phase I-III) for vaccines at their global network of 80 sites. Vaccine targets included COVID-19, RSV, Influenza, etc. Additional Therapeutic Area work included Infectious Disease (e.g. Monoclonal Antibodies for COVID-19) and GI (NASH and IBD).

Biotech company developing therapeutics to address cancer treatment toxicities, such as oral mucositis and peripheral neuropathy.

Advanced molecular diagnostics company focused on precision medicine, pharmacogenomics, direct -to -consumer diagnostic testing using a digital health platform.

Publicly traded Australian biopharmaceuticals company marketing antibody-based products to prevent infectious diseases.

Led cross-functional global Operating Team and drove highly successful business expansion into emerging markets including China, India, South America as well as Europe.Led development of multiple vaccine delivery platforms through full product life cycle. Senior-level engagement with FDA, CDC, OSHA, international agencies and Ministries of Health. Established signature Public-Private Partnership with UNICEF to eliminate neonatal tetanus by immunizing 90 million women over 5 years